Diane Lejeune

Uniquely combining science and business, I have developed over 25 years an end-to-end expertise in innovation for new medications (drugs & biologics), vaccines, medical devices, diagnostics & digital health solutions, in a variety of therapeutic areas, both in large companies and startups.
I have developed this expertise from the strategy & operations side, in research/discovery, development/D&D, V&V, clinical, regulatory, medical affairs, portfolio strategy & portfolio management, commercialization, IP, as well as through a Joint Venture, and through Venture Capital.
This expertise, I enjoy using to advise companies in biotech-medtech-digital health.
I also enjoy bringing it to board of directors where I already have had and am having director mandate; I wish to continue doing so.
I feel at ease advising companies in healthcare: biotech, medtech, digital health, whether start-ups/scales-ups, venture capital funds, or pharmaceuticals /medical devices corporations.
My strengths reside in defining long-term strategy and translating it into what needs to be done to achieve success.